MBIO: Mustang Bio Inc Price Target Chart

Symbol and logo of brand Mustang Bio, Inc. (MBIO)

Mustang Bio, Inc. (MBIO) owns an autonomous gene therapy manufacturing facility in Massachusetts, ensuring production stability. The business relies on collaborations with top U.S. scientists to implement cutting-edge treatments for rare pathologies. The company is currently optimizing expenses through asset sales, and its indicator stands at 498.63. This chart illustrates the price action for the company.

Mustang Bio, Inc. (MBIO): Price Target Chart from 07/04/2022 to 11/12/2026

Metric breakdowns and analytics for Mustang Bio, Inc. (MBIO)

- market price and analyst price targets:
Stock Quotes mustangbio.com|MBIO - Analyst Consensus Forecast
- market capitalization information:
Market Value Mustang Bio Corp|MBIO - Enterprise Value
- issuer book value statistics:
Net Assets per Share Mustang Bio|MBIO - Company Book Value|Market-to-Book Ratio mustangbio.com|MBIO - Company Total Assets
- debt obligations and liquidity statistics:
Debt to Equity Ratio Mustang Bio, Inc.|MBIO - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio mustangbio.com|MBIO - Company Aggregate Debts|Debts to Book Capitalization Mustang Bio Corp|MBIO - Company Long-Term Debt|Company Current Liabilities Mustang Bio|Quick Ratio mustangbio.com
- net income and valuation ratios data:
MBIO - Company Net Income|Company Profit Forecast Mustang Bio, Inc.|MBIO - Price to Earnings Ratio|Market Cap to Future Earnings Ratio mustangbio.com|MBIO - PEG Multiple|EV/EBITDA Multiple Mustang Bio Corp|MBIO - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Mustang Bio|MBIO - Net earnings per share (EPS TTM)|Net earnings per share growth for the trailing year mustangbio.com|MBIO - Net earnings per share growth this year|Expected earnings per share trend next year Mustang Bio, Inc.
General company analysis:MBIO Mustang Bio Inc
Manufactured products of Mustang Bio Inc

Professional asset selection requires aligning market expectations with current borrowing costs to filter out overvalued securities. This indicator aggregates average analyst price targets, reflecting the balance of supply and demand, which is critical for Mustang Bio, Inc. (MBIO), whose capitalization depends on the success of gene therapy clinical trials rather than revenue; track these patterns through changes in the consensus valuation of the security.

Competitors of Mustang Bio, Inc.

Consensus Target tempus.com TEM|Analyst Consensus Forecast QGEN (Qiagen)|Ionis Pharmaceuticals, Inc. - Price Target Chart|Repligen Corp. - Analyst Consensus Forecast|Analyst Median Target Avidity Corp RNA|CRISPR Therapeutics AG (CRSP) - Price Target Chart|Average Forecast Price genedx.com (WGS)|RARE (Ultragenyx) - Analyst Consensus Forecast|Broker Consensus Forecast BEAM (Beam Therapeutics Inc)|Price Target Chart Sarepta Therapeutics Inc (SRPT)|Twist Bioscience Corp - Broker Consensus Forecast|Analyst Consensus Forecast TXG (10x Genomics, Inc.)|Analyst Consensus Forecast intelliatx.com NTLA|STOK - Price Target Chart|BioLife Solutions Inc (BLFS) - Consensus Target|WVE (Wave Life Sciences Corp) - Consensus Target|Maze Therapeutics Corp (MAZE) - Analyst Consensus Forecast|Price Target Chart Sionna Therapeutics Inc|primemedicine.com (PRME) - Analyst Median Target|Consensus Target TSHA (Taysha Gene Therapies, Inc.)|Analyst Forecast Prices QURE|Analyst Consensus Forecast MGTX (MeiraGTx PLC)|Analyst Consensus Forecast REGENXBIO Corp RGNX|SLDB - Price Target Chart|OCGN (ocugen.com) - Broker Consensus Forecast|PACB: Analyst Consensus Forecast|Analyst Target Range Benitec Biopharma Inc BNTC|Consensus Target DSGN|RCKT: Fair Value Consensus|Analyst Consensus Forecast FDMT|Price Target Chart LXEO (lexeotx.com)|Analyst Consensus Forecast KRRO (Korro Bio)|Analyst Median Target Editas Medicine Inc (EDIT)|SLN - Price Target Chart|Average Forecast Price ProQR Therapeutics N.V.|CDXS (codexis.com) - Consensus Target|sangamo.com - Fair Value Consensus|NAUT (Nautilus Biotechnology, Inc.) - Analyst Consensus Forecast|Metagenomi Inc. (MGX) - Analyst Median Target|Price Target Chart Precision BioSciences (DTIL)|generationbio.com - Broker Consensus Forecast|Analyst Consensus Forecast BOLD (Boundless Bio, Inc.)|XCUR - Consensus Target|IMNN: Consensus Target|Analyst Median Target Phio Pharmaceuticals PHIO|transcodetherapeutics.com (RNAZ) - Price Target Chart|Consensus Target Bionano Genomics|APDN (Applied DNA Sciences) - Analyst Consensus Forecast|Price Target Chart BLUE|Analyst Consensus Forecast IPA|Analyst Median Target Omega Therapeutics Inc|Price Target Chart Singular Genomics Systems Inc OMIC|Regulus (RGLS) - Average Forecast Price|Syros Pharmaceuticals - Analyst Consensus Forecast|TBIO (telesisbio.com) - Broker Consensus Forecast|TRACON Pharmaceuticals, Inc. (TCON) - Price Target Chart|Broker Consensus Forecast UBX